MedPath

Impact of a cardiac rehabilitation program versus coronary revascularization in patients with stable coronary artery disease

Conditions
<p>Stable angina pectoris</p>
Registration Number
NL-OMON24082
Lead Sponsor
Maxima Medisch Centrum
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
216
Inclusion Criteria

A diagnosis of SAP with residual angina symptoms after OMT
- Established ischemia (assessed by SPECT, PET, Stress ultrasound, CMR, or cycle ergometry)
- Access to a personal computer, laptop or tablet with Internet connectivity at home.
- Access to a mobile phone with short message service (SMS) functionality to login to the web application with two-factor authentication.

Exclusion Criteria

An echocardiography and coronary angiography (usual care group) or coronary computed tomography (CT)-angiography (CR group) will be performed to exclude high-risk patients with a reduced left ventricular function (i.e. left ventricular ejection fraction <35%). After randomisation patients will also be screened for stenosis of the left main coronary artery through computed tomography (intervention group) or coronary angiogram (control group). For these patients previous work revealed the potential prognostic benefit of revascularization, in terms of mortality, also supported by latest guidelines on myocardial revascularization with a class 1A indication for revascularization.
Other exclusion criteria include:
1.PCI or CABG in the past year
2.Acute coronary syndrome in past 2 months
3.Angina symptoms at rest or rapidly progressive (i.e. unstable angina)
4.Ischemic threshold <50 watts
5.New-York Heart Association class III-IV heart failure symptoms
6.Advanced chronic kidney failure (i.e. estimated Glomerular Filtration rate <30ml/min)
7.Severe ventricular arrhythmia or exercise-induced arrythmia at baseline testing
8.A comorbidity precluding exercise training (e.g. orthopaedic, neurological or cognitive conditions) or other contra-indications for exercise training.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath